Salivary production in Parkinson's disease

Movement Disorders

Volumn 20, Issue 2, 2005, Pages 204-207

  Proulx, Melisa ^a,b   de Courval, François P ^a   Wiseman, Michael A ^c   Panisset, Michel ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Drooling; Dysphagia; Hypersialorrhea; Levodopa; Parkinson's disease

Indexed keywords

AMANTADINE; LEVODOPA;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DOSE RESPONSE; FEMALE; HUMAN; HYPERSALIVATION; HYPOSALIVATION; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SALIVATION; SEX DIFFERENCE; XEROSTOMIA;

AGED; ANTIPARKINSON AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; SALIVATION; SECRETORY RATE; SEX FACTORS; XEROSTOMIA;

EID: 14944344198     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20189     Document Type: Article

References (26)

1. Edwards LL, Quigley EM, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology 1992;42:726-732.
2. Johnston BT, Li Q, Castell JA, Castell DO. Swallowing and esophageal function in Parkinson's disease. Am J Gastroenterol 1995;90:1741-1746.
3. Bagheri H, Damase-Michel C, Lapeyre-Mestre M, et al. A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol 1999;22:213-215.
4. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Clin Neurosci 1998;5:136-146.
5. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord 2002;8:277-284.
6. Persson M, Osterberg T, Granerus AK, Karlsson S. Influence of Parkinson's disease on oral health. Acta Odontol Scand 1992;50: 37-42.
7. Leopold NA, Kagel MC. Laryngeal deglutition movement in Parkinson's disease. Neurology 1997;48:373-376.
8. Leopold NA, Kagel MC. Pharyngo-esophageal dysphagia in Parkinson's disease. Dysphagia 1997;12:11-18.
9. Nagaya M, Kachi T, Yamada T, Igata A. Videofluorographic study of swallowing in Parkinson's disease. Dysphagia 1998;13:95-100.
10. Nilsson H. Quantitative aspects of swallowing. Sweden: Department of Neurology; 1998.
11. Schindler JS, Kelly JH. Swallowing disorders in the elderly. Laryngoscope 2002;112:589-602.
12. Jost WH. Treatment of drooling in Parkinson's disease with botulinum toxin. Mov Disord 1999;14:1057.
13. O'Sullivan JD, Bhatia KP, Lees AJ. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;55:606-607.
14. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
15. Lang AE. Clinical rating scales and videotape analysis. In: Koller WS, Paulson G, editors. Therapy of Parkinson's disease. New York: Marcel Dekker, Inc; 1990. p 3-30.
16. Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 2003;134:61-69.
17. Vivino FB, Al Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 1999;159: 174-181.
18. Bateson MC, Gibberd FB, Wilson RS. Salivary symptoms in Parkinson disease. Arch Neurol 1973;29:274-275.
19. Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ. Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 1987;37:1253-1255.
20. Edwards LL, Pfeiffer RF, Quigley EM, Holman R, Balluff M. Gastrointestinal symptoms in Parkinson's disease. Mov Disord 1991;6:151-156.
21. Eadie MJ, Tyrer JH. Alimentary disorders in parkinsonism. Aust Ann Med 1965;14:13-22.
22. Pazo JH, Tumilasci OR, Medina JH. Studies on the mechanisms of L-dopa-induced salivary secretion. Eur J Pharmacol 1981;69:255-261.
23. Pazo JH, Gomez-Gonzales M, Tumilasci OR, O'Donnell P, Murer G. The sialagogue response of striatal dopamine receptors to L-dopa is not influenced by castration or chronic estrogen treatment. Brain Res Bull 1986;16:1-4.
24. Tscheng DZ. Sialorrhea - therapeutic drug options. Ann Pharmacother 2002;36:1785-1790.
25. Nunn JH. Drooling: review of the literature and proposals for management. J Oral Rehabil 2000;27:735-743.
26. Mancini F, Zangaglia R, Cristina S, et al. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 2003;18:685-688.